v3.26.1
Note 9 - Stockholders' Equity and Stock Repurchase Program
12 Months Ended
Dec. 31, 2025
Notes to Financial Statements  
Equity [Text Block]

Note 9. Stockholders Equity and Stock Repurchase Program

 

Stockholders Equity

 

The 883,000 shares of $0.001 par value Series A preferred stock issued and outstanding as of December 31, 2025 and 2024, valued at $3,532,000 are non-voting and non-convertible preferred stock with a 5.0% cumulative annual dividend rate payable when declared by the Board of Directors and $4 per share liquidation preference over common stock, and must be paid before any distribution is made to common stockholders. These preferred shares were issued to Lyte Optronics, Inc. stockholders in connection with the completion of our acquisition of Lyte Optronics, Inc. on May 28, 1999.

 

Changes in AXT, Inc.s ownership interests in consolidated subsidiaries

 

During 2025 and 2024, there were no changes in the Company’s ownership interests in its consolidated subsidiaries that affected the Company’s equity.

 

Stock Repurchase Program

 

On October 27, 2014, our Board of Directors approved a stock repurchase program pursuant to which we may repurchase up to $5.0 million of our outstanding common stock. These repurchases can be made from time to time in the open market and are funded from our existing cash balances and cash generated from operations. During 2015, we repurchased approximately 908,000 shares at an average price of $2.52 per share for a total purchase price of approximately $2.3 million under the stock repurchase program. No shares were repurchased during 2025, 2024 and 2023 under this program. As of December 31, 2025, approximately $2.7 million remained available for future repurchases under this program. 

 

By the terms of the Series A preferred stock, so long as any shares of Series A preferred stock are outstanding, neither the Company nor any subsidiary of the Company shall redeem, repurchase or otherwise acquire any shares of common stock, unless all accrued dividends on the Series A preferred stock have been paid. During 2013 and 2015, we repurchased shares of our outstanding common stock. As of December 31, 2015, the Series A preferred stock had cumulative dividends of $2.9 million and we included this amount in “Accrued liabilities” in our consolidated balance sheets. In 2025, 2024 and 2023, we did not repurchase any of our outstanding common stock. If we are required to pay the cumulative dividends on the Series A preferred stock, our cash and cash equivalents would be reduced. We account for the cumulative year-to-date dividends on the Series A preferred stock when calculating our earnings per share.